| 前收盘价格 | 3.06 |
| 收盘价格 | 3.10 |
| 成交量 | 1,137,936 |
| 平均成交量 (3个月) | 596,505 |
| 市值 | 348,832,128 |
| 价格/销量 (P/S) | 6.43 |
| 股市价格/股市净资产 (P/B) | 1.23 |
| 52周波幅 | |
| 利润日期 | 13 Jan 2025 |
| 营业毛利率 | -110.92% |
| 营业利益率 (TTM) | -118.33% |
| 稀释每股收益 (EPS TTM) | -0.400 |
| 季度收入增长率 (YOY) | -8.40% |
| 总债务/股东权益 (D/E MRQ) | 9.44% |
| 流动比率 (MRQ) | 12.23 |
| 营业现金流 (OCF TTM) | -31.46 M |
| 杠杆自由现金流 (LFCF TTM) | -13.08 M |
| 资产报酬率 (ROA TTM) | -13.12% |
| 股东权益报酬率 (ROE TTM) | -19.63% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 看跌 |
| Medical Devices (全球的) | 看跌 | 看跌 | |
| 股票 | MaxCyte, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
-0.9
| 分析师共识 | -2.0 |
| 内部交易活动 | 1.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -0.90 |
|
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 1.45% |
| 机构持股比例 | 75.79% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| River Global Investors Llp | 31 Dec 2024 | 3,253,192 |
| Mudita Advisors Llp | 31 Dec 2024 | 3,223,407 |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| AL-WAKEEL YASIR B. | 2.11 | - | 29,210 | 61,633 |
| BALTHROP PATRICK J | 2.11 | - | 29,210 | 61,633 |
| BROOKE WILLIAM W | 2.11 | - | 29,210 | 61,633 |
| COLLINS CYNTHIA | 2.11 | - | 29,210 | 61,633 |
| DOUGLAS RICHARD | 2.11 | - | 29,210 | 61,633 |
| ERCK STANLEY C | 2.11 | - | 29,210 | 61,633 |
| HEMRAJANI REKHA | 2.11 | - | 29,210 | 61,633 |
| JOHNSTON JOHN JOSEPH | 2.11 | - | 29,210 | 61,633 |
| 累积净数量 | 233,680 | |||
| 累积净值 ($) | 493,065 | |||
| 累积平均购买 ($) | 2.11 | |||
| 累积平均卖出 ($) | - | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| AL-WAKEEL YASIR B. | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| BALTHROP PATRICK J | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| BROOKE WILLIAM W | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| COLLINS CYNTHIA | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| DOUGLAS RICHARD | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| ERCK STANLEY C | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| HEMRAJANI REKHA | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
| JOHNSTON JOHN JOSEPH | 董事 | 18 Jun 2025 | 获得 (+) | 29,210 | 2.11 | 61,633 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合